Electrochemical Behavior and Square Wave Voltammetric Determination of Doxorubicin Hydrochloride

  • Published : 2004.01.01

Abstract

The electrochemical behavior of doxorubicin hydrochloride was investigated by cyclic voltammetry (CV) and square wave voltammetry (SWV). From CV and SWV studies of doxorubicin hydrochloride in the acetate buffers of various pH values, it was found that protons were involved in the reduction of the antibiotic at the $H^+/e^$- ratio at one ( $\DeltaEp/pH =-53 ∼ -61 mV at 23^{\circ}C$), proposing the electrochemical reduction of the quinone moiety in its anthraquinone aglycone. Its electrochemical behavior was pseudo-reversible in the acetate buffer of pH 3.5 by exhibiting the well-defined single cathodic and anodic waves and the ratio of $lp^a/lp^c$ at approximately one over the scan rates of 10∼100 mV/s. Fast and sensitive SWV showing a single peak of doxorubicin has been applied for its quantitative analysis using an acetate buffer of pH 3.5. A linearity was obtained when the peak currents (lp) were plotted against concentrations of doxorubicin in the range of $5.0\times10^{-7} M∼1.0\times10^{-5}$M with a detection limit of $1.0\times10^{-7}$ M.

Keywords

References

  1. Alvarez-Cedron, L., Sayalero, M. L., and Lanao, J. M., High-performance chromatographic validated assay of doxorubicin in rat plasma and tissues. J. Chromatogr. B, 721, 271-278 (1999) https://doi.org/10.1016/S0378-4347(98)00475-7
  2. Buehler, P W., Robles, S. J., Adami, G. R, Gajee, R, and Negrusz, A., Analysis of doxorubicin in cell culture media and human plasma using solid phase extraction and HPLC. Chromatographia, 49, 557-561 (1999) https://doi.org/10.1007/BF02467759
  3. European Pharmacopoeia Commission, European Pharmacopoeia, Councilof Europe, Strasbourg, 785 (1997)
  4. Hu, Q., Zhang, L., Zhou, T., and Fang, Y, Determination of daunorubicin in human urine by capillary zone electrophoresis with amperometric detection. Anal. Chim. Acta, 416, 15-19 (2000) https://doi.org/10.1016/S0003-2670(00)00856-4
  5. Korea Food and Drug Administration, The Minimum Requirements for Antibiotic Products of Korea, Yakup Shinmoon Co., Korea, 318 (2000)
  6. Ricciarello, R, Pichini, S., Pacifici, R, Altieri, I., Pellegrini, M., Fattorossi, A. and Zuccaro, P., Simultaneous determination of epirubicin, doxorubicin and their principal metabolites in human plasma by high-performance liquid chromatography and electrochemical detection. J. Chromatogr. B, 707, 219-225 (1998) https://doi.org/10.1016/S0378-4347(97)00610-5
  7. Sastry, C. S. P. and Rao, J., Determination of doxorubicin hydrochloride by visible spectrophotometry. Talanta, 43, 1827-1835 (1996) https://doi.org/10.1016/0039-9140(96)01932-7
  8. United States Pharmacopeial Convention, U. S. Pharmacopeia & National Formulary, National Publishing, Philadelphia, PA, 606 (2000)
  9. Zagotto, G.,Gatto, B., Moro, S., Sissi, C., and Palumbo, M., Anthracyclines: recent developments in their separation and quantitation. J. Chromatogr. B: Biomed. Sci. Appl., 764, 161-171 (2001) https://doi.org/10.1016/S0378-4347(01)00346-2